Suchergebnisse - "Nagao, Shunsuke"

PubPharm (18)

1

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Kawai, T. | Sun, B. | Yoshino, H. | +13

2

EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder

enthalten in: Kidney international | 2020

von Tsuboi, Y. | Ohtomo, S. | Ichida, Y. | +7

3

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Erschienen: 2020

von Kawai, T. | Sun, B. | Yoshino, H. | +13

4

Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2017

von Sekiguchi, N. | Nagao, S. | Takanashi, K. | +5

5

Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib

enthalten in: Xenobiotica | 2017

von Sekiguchi, N. | Nagao, S. | Takanashi, K. | +5

6

Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib

enthalten in: Xenobiotica | 2016

von Sekiguchi, N. | Nagao, S. | Takanashi, K. | +5

7

In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2015

von Yamane, M. | Kawashima, K. | Yamaguchi, K. | +13

8

In vitroprofiling of the metabolism and drug–drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP

enthalten in: Xenobiotica | 2015

von Yamane, M. | Kawashima, K. | Yamaguchi, K. | +13

9

In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP

enthalten in: Xenobiotica | 2015

von Yamane, M. | Kawashima, K. | Yamaguchi, K. | +13

10

A useful model capable of predicting the clearance of cytochrome 3A4 (CYP3A4) substrates in humans : validity of CYP3A4 transgenic mice lacking their own Cyp3a enzymes

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2014

von Mitsui, T. | Nemoto, T. | Miyake, T. | +5